Home|Insights|Antibody-based drug discovery at the speed of light
Antibody-based drug discovery at the speed of light
white paper
internal
The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.